The significance of the recent research is that if the protein signature discovered genuinely identifies people at particularly high risk, it could eventually help make screening programmes for lung cancer more efficient. But whether treatment with the drug Canakinumab actually reduces the incidence or progression of lung cancer remains uncertain
The significance of the recent research is that if the protein signature discovered genuinely identifies people at particularly high risk, it could eventually help make screening programmes for lung cancer more efficient. But whether treatment with the drug Canakinumab actually reduces the incidence or progression of lung cancer remains uncertain
<iframe src="https://hindustansphere.com/embed/cluster/fb0d11b931205683e4d432603cc9ea10097b6e72" width="100%" height="320" style="border:0;max-width:680px" loading="lazy" title="Can lung cancer be prevented using a drug?"></iframe>
The significance of the recent research is that if the protein signature discovered genuinely identifies people at particularly high risk, it could eventually help make screening programmes for lung cancer more efficient. But whether treatment with the drug Canakinumab actually reduces the incidence or progression of lung cancer remains uncertain
